Capital World Investors Lowers Stock Position in Corteva, Inc. $CTVA

Capital World Investors reduced its stake in Corteva, Inc. (NYSE:CTVA) by 8.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 21,355,189 shares of the company’s stock after selling 1,884,881 shares during the quarter. Capital World Investors owned about 3.16% of Corteva worth $1,431,438,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also bought and sold shares of CTVA. Norges Bank purchased a new stake in Corteva in the fourth quarter valued at approximately $504,001,000. Northwestern Mutual Wealth Management Co. raised its stake in Corteva by 6,527.4% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 3,148,212 shares of the company’s stock valued at $211,025,000 after purchasing an additional 3,100,709 shares in the last quarter. Perpetual Ltd raised its stake in Corteva by 78,688.5% in the fourth quarter. Perpetual Ltd now owns 2,615,779 shares of the company’s stock valued at $175,336,000 after purchasing an additional 2,612,459 shares in the last quarter. Amundi raised its stake in Corteva by 125.3% in the third quarter. Amundi now owns 3,415,554 shares of the company’s stock valued at $219,620,000 after purchasing an additional 1,899,248 shares in the last quarter. Finally, Squarepoint Ops LLC raised its stake in Corteva by 423.6% in the third quarter. Squarepoint Ops LLC now owns 1,738,139 shares of the company’s stock valued at $117,550,000 after purchasing an additional 1,406,199 shares in the last quarter. 81.54% of the stock is owned by hedge funds and other institutional investors.

Corteva Stock Down 0.5%

Shares of Corteva stock opened at $77.06 on Friday. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.03 and a current ratio of 1.47. Corteva, Inc. has a 52-week low of $60.53 and a 52-week high of $85.63. The stock has a market capitalization of $51.54 billion, a price-to-earnings ratio of 45.33, a P/E/G ratio of 2.36 and a beta of 0.57. The company’s 50 day moving average price is $81.17 and its 200-day moving average price is $74.94.

Corteva (NYSE:CTVA) last issued its earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.18 by $0.32. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The firm had revenue of $4.91 billion for the quarter, compared to analysts’ expectations of $4.64 billion. During the same quarter last year, the business earned $1.13 earnings per share. The business’s revenue was up 11.0% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities research analysts forecast that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, June 15th. Stockholders of record on Monday, June 1st will be issued a $0.18 dividend. The ex-dividend date is Monday, June 1st. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. Corteva’s dividend payout ratio (DPR) is currently 42.35%.

Analysts Set New Price Targets

A number of research analysts have commented on CTVA shares. Berenberg Bank increased their price target on shares of Corteva from $68.00 to $78.00 and gave the company a “hold” rating in a research report on Thursday, March 26th. Zacks Research cut shares of Corteva from a “strong-buy” rating to a “hold” rating in a research report on Friday, February 20th. Wall Street Zen cut shares of Corteva from a “buy” rating to a “hold” rating in a research report on Saturday, February 7th. Royal Bank Of Canada increased their price target on shares of Corteva from $95.00 to $97.00 and gave the company an “outperform” rating in a research report on Thursday, May 7th. Finally, Citigroup increased their price target on shares of Corteva from $83.00 to $85.00 and gave the company a “neutral” rating in a research report on Thursday, May 7th. Fourteen analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. Based on data from MarketBeat, Corteva has a consensus rating of “Moderate Buy” and a consensus target price of $88.67.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.